Drugplain

Thiamine 100 mg/mL

Thiamine Hydrochloride · INJECTION, SOLUTION · NorthStar Rx LLC

10 Recalls on Record
Plain English

Thiamine is a injection, solution containing thiamine hydrochloride at 100 mg/mL, taken intramuscular. Manufactured by NorthStar Rx LLC.

Key Facts

Brand Name
Thiamine
Generic Name
Thiamine Hydrochloride
NDC Code (Product)
72603-139
Manufacturer
NorthStar Rx LLC
Strength
100 mg/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Marketing Status
Application #
ANDA215692
Marketing Start
04/20/2023

Recall History

10 Recalls on Record
Class II11/17/2016

Tri-Coast Pharmacy

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated
Class II11/17/2016

Tri-Coast Pharmacy

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated
Class II12/17/2018

Promise Pharmacy, LLC

Lack of sterility assurance.

TerminatedVoluntary: Firm initiated
Class II12/08/2022

McGuff Compounding Pharmacy Services, Inc.

Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.

TerminatedVoluntary: Firm initiated
Class II02/05/2026

Fresenius Kabi Compounding, LLC

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated
Class II12/22/2022

Pharmacy Innovations

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

TerminatedVoluntary: Firm initiated
Class III05/03/2021

Mylan Institutional LLC

Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

TerminatedVoluntary: Firm initiated
Class II05/13/2016

Medaus, Inc.

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class II05/24/2022

US Specialty Formulations LLC

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class II11/22/2023

AnazaoHealth Corporation

Presence of Particulate Matter.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use933 reports
nausea803 reports
drug ineffective786 reports
dyspnoea759 reports
diarrhoea712 reports
pain698 reports
fatigue650 reports
confusional state643 reports
vomiting580 reports
dizziness550 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. Thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in Wernicke's encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. It is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. Thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption. Thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually be given.

Dosage & Administration

DOSAGE AND ADMINISTRATION "Wet" beriberi with myocardial failure must be treated as an emergency cardiac condition, and thiamine must be administered slowly by the IV route in this situation (see WARNINGS ). In the treatment of beriberi, 10 to 20 mg of thiamine hydrochloride are given IM three times daily for as long as two weeks. (See WARNINGS regarding repeated injection of thiamine.) An oral therapeutic multivitamin preparation containing 5 to 10 mg thiamine, administered daily for one month, is recommended to achieve body tissue saturation. Infantile beriberi that is mild may respond to oral therapy, but if collapse occurs, doses of 25 mg may cautiously be given IV. Poor dietary habits should be corrected and an abundant and well-balanced dietary intake should be prescribed. Patients with neuritis of pregnancy in whom vomiting is severe enough to preclude adequate oral therapy should receive 5 to 10 mg of thiamine hydrochloride IM daily. In the treatment of Wernicke-Korsakoff syndrome, thiamine hydrochloride has been administered IV in an initial dose of 100 mg, followed by IM doses of 50 to 100 mg daily until the patient is consuming a regular, balanced diet. (See WARNINGS reg

Warnings

WARNINGS WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration. Serious hypersensitivity/anaphylactic reactions can occur, especially after repeated administration. Deaths have resulted from IV or IM administration of thiamine (see ADVERSE REACTIONS ). Routine testing for hypersensitivity, in many cases, may not detect hypersensitivity. Nevertheless, a skin test should be performed on patients who are suspected of drug allergies or previous reactions to thiamine, and any positive responders should not receive thiamine by injection. If hypersensitivity to thiamine is suspected (based on histo

Contraindications

CONTRINDICATIONS A history of sensitivity to thiamine or to any of the ingredients in this drug is a contraindication. (See WARNINGS for further information.)

Adverse Reactions

ADVERSE REACTIONS An occasional individual may develop a hypersensitivity or life threatening anaphylactic reaction to thiamine, especially after repeated injections. Collapse and death have been reported. A feeling of warmth, pruritus, urticaria, weakness, sweating, nausea, restlessness, tightness of the throat, angioneurotic edema, cyanosis, pulmonary edema, and hemorrhage into the gastrointestinal tract have also been reported. Some tenderness and induration may follow IM use (see WARNINGS ).

Frequently Asked Questions

What is Thiamine used for?

Thiamine contains Thiamine Hydrochloride. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.

Is Thiamine a controlled substance?

Thiamine is not classified as a controlled substance by the DEA.

What is the generic name for Thiamine?

The generic name for Thiamine is Thiamine Hydrochloride. There are 11 other brand versions of Thiamine Hydrochloride.

What is the NDC code for Thiamine 100 mg/mL?

The NDC (National Drug Code) for Thiamine 100 mg/mL is 72603-139, listed by NorthStar Rx LLC.